Inhibition of DNA‑PK activity sensitizes A549 cells to X‑ray irradiation by inducing the ATM‑dependent DNA damage response

Yang,Lina; Yang,Xinrui; Tang,Yiwei; Zhang,Defu; Zhu,Lijie; Wang,Shengnan; Wang,Bo; Ma,Tao

doi:10.3892/mmr.2018.8828

Inhibition of DNA‑PK activity sensitizes A549 cells to X‑ray irradiation by inducing the ATM‑dependent DNA damage response

Authors:
- Lina Yang
- Xinrui Yang
- Yiwei Tang
- Defu Zhang
- Lijie Zhu
- Shengnan Wang
- Bo Wang
- Tao Ma
View Affiliations

Affiliations: College of Food Science and Technology, Bohai University, Jinzhou, Liaoning 121013, P.R. China, Center for Therapeutic Research of Hepatocarcinoma, Beijing 302 Hospital, Beijing 100039, P.R. China
Published online on: March 29, 2018 https://doi.org/10.3892/mmr.2018.8828
Pages: 7545-7552
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non‑small cell lung cancer (NSCLC) is radioresistant to X‑rays due to powerful cellular DNA damage repair mechanisms. DNA‑dependent protein kinase (DNA‑PK) is a key enzyme involved in DNA damage repair and the phenomenon and molecular mechanism of NSCLC radionsensitivity were investigated following inhibition of DNA‑PK activity. In the present study A549 cells were treated with the DNA‑PK inhibitor NU7026 and/or siRNA directed against ataxia telangiectasia mutated (ATM), followed by exposure to 4 Gy X‑ray irradiation. Radiosensitivity, DNA damage, apoptosis and protein expression were measured by colony formation assay, γH2AX foci immunofluorescence, Annexin V/PI staining and western blotting, respectively. A Balb/c‑nu/nu xenograft mouse model was established by subcutaneous injection of A549 cells and was used to examine the effect of administering NU7026 via intraperitoneal injection prior to 4 Gy X‑ray exposure. The xenograft tumors were weighed and observed by hematoxylin and eosin staining after irradiation. NU7026 treatment followed by X‑ray irradiation significantly decreased the colony formation ratio of A549 cells, and increased γH2AX foci and cell apoptosis. Furthermore, the combined treatment of NU7026 and X‑rays resulted in growth inhibition and cell apoptosis in A549 xenograft tumors. Consequently, apoptosis regulators full‑length transactivating (TA) p73 and an N‑terminally truncated (DN) p73 were upregulated and downregulated respectively, leading to activation of glucosyltransferases and Rab‑like GTPase activators and myotubularins domain‑containing 4 (GRAMD4) protein to reduce the Bcl‑2/Bax protein ratio. In addition, ATM siRNA efficiently prevented γH2AX foci formation, and enhanced NU7026‑induced inhibition of survival and promoted apoptosis. In conclusion, inhibition of DNA‑PK activity increased the radiosensitivity of A549 cells to X‑ray irradiation. NU7026 treatment activated the ATM‑dependent DNA damage response and induced p73 apoptosis pathway. DNA‑PK inhibitor may be an effective constituent of radiosensitization products. DNA damage repair pathway could be a potential target for radiosensitization.

View Figures

View References

1	Rodin D, Grover S, Xu MJ, Hanna TP, Olson R, Schreiner LJ, Munshi A, Mornex F, Palma D and Gaspar LE: International Association for the Study of Lung Cancer Advanced Radiation Technology Committee: Radiotherapeutic management of non-small cell lung cancer in the minimal resource setting. J Thorac Oncol. 11:21–29. 2016. View Article : Google Scholar : PubMed/NCBI
2	DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
3	Yang HJ, Kim N, Seong KM, Youn H and Youn B: Investigation of radiation-induced transcriptome profile of radioresistant non-small cell lung cancer A549 cells using RNA-seq. PLoS One. 8:e593192013. View Article : Google Scholar : PubMed/NCBI
4	Zhuang W, Li B, Long L, Chen L, Huang Q and Liang Z: Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer. 129:2720–2731. 2011. View Article : Google Scholar : PubMed/NCBI
5	Kim JS, Krasieva TB, Kurumizaka H, Chen DJ, Taylor AM and Yokomori K: Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells. J Cell Biol. 170:341–347. 2005. View Article : Google Scholar : PubMed/NCBI
6	Mahaney BL, Meek K and Lees-Miller SP: Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J. 417:639–650. 2009. View Article : Google Scholar : PubMed/NCBI
7	Lieber MR: The mechanism of human nonhomologous DNA end joining. J Biol Chem. 283:1–5. 2008. View Article : Google Scholar : PubMed/NCBI
8	Yajima H, Lee KJ, Zhang S, Kobayashi J and Chen BP: DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases. J Mol Biol. 385:800–810. 2009. View Article : Google Scholar : PubMed/NCBI
9	Yang SH, Kuo TC, Wu H, Guo JC, Hsu C, Hsu CH, Tien YW, Yeh KH, Cheng AL and Kuo SH: Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer. World J Gastroenterol. 22:7275–7288. 2016. View Article : Google Scholar : PubMed/NCBI
10	Yang L, Liu Y, Sun C, Yang X, Yang Z, Ran J, Zhang Q, Zhang H and Wang X and Wang X: Inhibition of DNA-PKcs enhances radiosensitivity and increases the levels of ATM and ATR in NSCLC cells exposed to carbon ion irradiation. Oncol Lett. 10:2856–2864. 2015. View Article : Google Scholar : PubMed/NCBI
11	Di CX, Yang LN, Zhang H, An LZ, Zhang X, Ma XF, Sun C, Wang XH, Yang R, Wu ZH and Si J: Effects of carbon-ion beam or X-ray irradiation on anti-apoptosis ΔNp73 expression in HeLa cells. Gene. 515:208–213. 2013. View Article : Google Scholar : PubMed/NCBI
12	Conforti F, Yang AL, Agostini M, Rufini A, Tucci P, Nicklison-Chirou MV, Grespi F, Velletri T, Knight RA, Melino G and Sayan BS: Relative expression of TAp73 and ΔNp73 isoforms. Aging (Albany NY). 4:202–205. 2012. View Article : Google Scholar : PubMed/NCBI
13	John K, Alla V, Meier C and Putzer BM: GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria. Cell Death Differ. 18:874–886. 2011. View Article : Google Scholar : PubMed/NCBI
14	Muppani N, Nyman U and Joseph B: TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell death. Oncotarget. 2:1145–1154. 2011. View Article : Google Scholar : PubMed/NCBI
15	Bailey SG, Cragg MS and Townsend PA: Family friction as ΔNp73 antagonises p73 and p53. Int J Biochem Cell Biol. 43:482–486. 2011. View Article : Google Scholar : PubMed/NCBI
16	Di C, Sun C, Li H, Si J, Zhang H, Han L, Zhao Q, Liu Y, Liu B, Miao G, et al: Diallyl disulfide enhances carbon ion beams-induced apoptotic cell death in cervical cancer cells through regulating Tap73/ΔNp73. Cell Cycle. 14:3725–3733. 2015. View Article : Google Scholar : PubMed/NCBI
17	Hassan HM, Dave BJ and Singh RK: TP73, an under-appreciated player in non-Hodgkin lymphoma pathogenesis and management. Curr Mol Med. 14:432–439. 2014. View Article : Google Scholar : PubMed/NCBI
18	Liu X, Sun C, Jin X, Li P, Ye F, Zhao T, Gong L and Li Q: Genistein enhances the radiosensitivity of breast cancer cells via G₂/M cell cycle arrest and apoptosis. Molecules. 18:13200–13217. 2013. View Article : Google Scholar : PubMed/NCBI
19	Cooper A, Garcia M, Petrovas C, Yamamoto T, Koup RA and Nabel GJ: HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature. 498:376–379. 2013. View Article : Google Scholar : PubMed/NCBI
20	Wang Y, Xue H, Cutz JC, Bayani J, Mawji NR, Chen WG, Goetz LJ, Hayward SW, Sadar MD, Gilks CB, et al: An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. Lab Invest. 85:1392–1404. 2005. View Article : Google Scholar : PubMed/NCBI
21	Vandersickel V, Depuydt J, Van Bockstaele B, Perletti G, Philippe J, Thierens H and Vral A: Early increase of radiation-induced gammaH2AX foci in a human Ku70/80 knockdown cell line characterized by an enhanced radiosensitivity. J Radiat Res. 51:633–641. 2010. View Article : Google Scholar : PubMed/NCBI
22	Shiloh Y and Ziv Y: The ATM protein kinase: Regulating the cellular response to genotoxic stress and more. Nat Rev Mol Cell Biol. 14:197–210. 2013. View Article : Google Scholar
23	Yang J, Yu Y, Hamrick HE and Duerksen-Hughes PJ: ATM, ATR and DNA-PK: Initiators of the cellular genotoxic stress responses. Carcinogenesis. 24:1571–1580. 2003. View Article : Google Scholar : PubMed/NCBI
24	Durocher D and Jackson SP: DNA-PK, ATM and ATR as sensors of DNA damage: Variations on a theme? Curr Opin Cell Biol. 13:225–231. 2001. View Article : Google Scholar : PubMed/NCBI
25	Jackson SP: DNA damage detection by DNA dependent protein kinase and related enzymes. Cancer Surv. 28:261–279. 1996.PubMed/NCBI
26	Yang C, Wang Q, Liu X, Cheng X, Jiang X, Zhang Y, Feng Z and Zhou P: NU7441 enhances the radiosensitivity of liver cancer cells. Cell Physiol Biochem. 38:1897–1905. 2016. View Article : Google Scholar : PubMed/NCBI
27	Tichy A, Durisova K, Salovska B, Pejchal J, Zarybnicka L, Vavrova J, Dye NA and Sinkorova Z: Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441. Radiat Environ Biophys. 53:83–92. 2014. View Article : Google Scholar : PubMed/NCBI
28	Niazi MT, Mok G, Heravi M, Lee L, Vuong T, Aloyz R, Panasci L and Muanza T: Effects of dna-dependent protein kinase inhibition by NU7026 on dna repair and cell survival in irradiated gastric cancer cell line N87. Curr Oncol. 21:91–96. 2014. View Article : Google Scholar : PubMed/NCBI
29	Chen H, Zeng X, Gao C, Ming P, Zhang J, Guo C, Zhou L, Lu Y, Wang L, Huang L, et al: A new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity. Sci Rep. 5:108932015. View Article : Google Scholar : PubMed/NCBI
30	Williamson CT, Muzik H, Turhan AG, Zamò A, O'Connor MJ, Bebb DG and Lees-Miller SP: ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors. Mol Cancer Ther. 9:347–357. 2010. View Article : Google Scholar : PubMed/NCBI
31	Weston VJ, Oldreive CE, Skowronska A, Oscier DG, Pratt G, Dyer MJ, Smith G, Powell JE, Rudzki Z, Kearns P, et al: The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Blood. 116:4578–4587. 2010. View Article : Google Scholar : PubMed/NCBI
32	Arlander SJ, Greene BT, Innes CL and Paules RS: DNA protein kinase-dependent G2 checkpoint revealed following knockdown of ataxia-telangiectasia mutated in human mammary epithelial cells. Cancer Res. 68:89–97. 2008. View Article : Google Scholar : PubMed/NCBI
33	Shen Y, Rehman FL, Feng Y, Boshuizen J, Bajrami I, Elliott R, Wang B, Lord CJ, Post LE and Ashworth A: BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency. Clin Cancer Res. 19:5003–5015. 2013. View Article : Google Scholar : PubMed/NCBI
34	Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM and Abraham RT: Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59:4375–4382. 1999.PubMed/NCBI
35	Rosenzweig KE, Youmell MB, Palayoor ST and Price BD: Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. Clin Cancer Res. 3:1149–1156. 1997.PubMed/NCBI
36	Critchlow SE, Bowater RP and Jackson SP: Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Curr Biol. 7:588–598. 1997. View Article : Google Scholar : PubMed/NCBI
37	Davidson D, Amrein L, Panasci L and Aloyz R: Small molecules, inhibitors of DNA-PK, targeting DNA repair and beyond. Front Pharmacol. 4:52013. View Article : Google Scholar : PubMed/NCBI
38	Blasina A, Hallin J, Chen E, Arango ME, Kraynov E, Register J, Grant S, Ninkovic S, Chen P, Nichols T, et al: Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1. Mol Cancer Ther. 7:2394–2404. 2008. View Article : Google Scholar : PubMed/NCBI
39	Sausville EA, Arbuck SG, Messmann R, Headlee D, Bauer KS, Lush RM, Murgo A, Figg WD, Lahusen T, Jaken S, et al: Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms. J Clin Oncol. 19:2319–2333. 2001. View Article : Google Scholar : PubMed/NCBI